Skip to content

- Search for:
About
Pipeline
- Pipeline
- Platform
Cord Blood Bank

English
- English
- 中文 (香港)

0

Cart

No products in the cart.

Return to shop

Monthly Archives: October 2025

Uncategorized

Mononuclear Therapeutics Passed Regular AABB Assessment

Posted on 2025-10-152026-06-29 by admin

Continue reading →

Posted in Uncategorized

About

Mononuclear Therapeutics (MonoTx) Limited collects, processes, tests and banks human umbilical cord blood (UCB) and component for research and disease treatment.

Latest Posts

15
Oct

Mononuclear Therapeutics Passed Regular AABB Assessment Comments Off on Mononuclear Therapeutics Passed Regular AABB Assessment
18
Aug

META-PARADE: Crosstalk of MonoTx and Keith Lam & Dimension Plus — Mononuclear Vitality Comments Off on META-PARADE: Crosstalk of MonoTx and Keith Lam & Dimension Plus — Mononuclear Vitality
10
Jan

08/01/2020 Press Release Comments Off on 08/01/2020 Press Release
19
Dec

Mononuclear Therapeutics Earns AABB Accreditation Comments Off on Mononuclear Therapeutics Earns AABB Accreditation

Archives

October 2025 (1)
August 2022 (1)
January 2020 (1)
December 2019 (1)

About us

Mononuclear Therapeutics (MonoTx^®) develops umbilical cord blood mononuclear cellular therapies, extracellular vesicles and other products to treat disease and save lives.

Latest News

15
Oct

Mononuclear Therapeutics Passed Regular AABB Assessment Comments Off on Mononuclear Therapeutics Passed Regular AABB Assessment

© Copyright 2026 Mononuclear Therapeutics^®

Search for:
About
Pipeline
- Pipeline
- Platform
Cord Blood Bank